BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Glide Pharma 

45B Milton Park

Abingdon  Oxfordshire  OX14 4RU  United Kingdom
Phone: 44-0-8700-853700 Fax: 44-0-8700-853704


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014 7:14:10 AM
Glide Pharma Appoints Richard Bungay As Chief Financial Officer And Tony Mills As Director Of Business Development 7/8/2014 9:11:58 AM
Glide Pharma Appoints Bryan G Morton as Chairman and Announces Board Changes 10/9/2013 9:39:15 AM
Glide Pharma Announces Design Optimisation Agreement With Nypro Healthcare for Scale Up of Solid Dose Delivery Device 7/2/2013 9:38:01 AM
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine 4/30/2013 10:21:06 AM
Glide Pharma Appoints Dr Mark Carnegie-Brown as Chief Executive 3/6/2013 1:40:34 PM
Glide Pharma Announces Completion of $21.4 Million Investment 2/26/2013 7:15:10 AM
Glide Pharma Announces £2.3 Million ($3.7 Million) Award From UK Biomedical Catalyst for Development of Osteoporosis Treatment 11/5/2012 12:06:10 PM
Glide Pharma Completes Oversubscribed $4.3 Million Investment Round 2/10/2010 7:09:58 AM
Glide Pharma Secures Further £2.2 Million to Accelerate Development Programme 10/13/2008 10:33:20 AM
12